BCRX
BioCryst Pharmaceuticals Inc.
$6.83
-$0.50(-6.76%)
48
Overall
30
Value
54
Tech
60
Quality
Market Cap
$1.52B
Volume
6.26M
52W Range
$6.00 - $11.31
Target Price
$20.27
Key Metrics Overview
| Market Cap | $1.52B | P/E Ratio | 40.15 |
| 52W High | $11.31 | 52W Low | $6.00 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 25.3% | 52W Position | 15.5% |
| Overall Score | 48 | Value Score | 30 |
| Quality Score | 60 | Technical Score | 54 |
Growth Analysis
| EPS Current Est | $0.17 | EPS Next Est | $0.39 |
| EPS Growth Est | +129.4% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $6.83 | -6.8% | 6.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW